Skip to main content

Table 7 Adverse events (n > 2)

From: Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial

Adverse event

AP301 (n = 20)

Placebo (n = 20)

Total (n = 40)

Tracheostomy

5 (25)

8 (40)

13 (32.5)

Anemia

3 (15)

6 (30)

9 (22.5)

Worsening of existing anemia

5 (25)

2 (10)

7 (17.5)

Cardiac arrest

5 (25)

1 (5)

6 (15)

Fever

1 (5)

4 (20)

5 (12.5)

Thrombopenia

3 (15)

1 (5)

4 (10)

Leucocytosis

3 (15)

1 (5)

4 (10)

Atrial flutter/fibrillation

1 (5)

3 (15)

4 (10)

Pleural effusion

0 (0)

3 (15)

3 (7.5)

  1. Data are presented as n (%)